Diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non-infectious diseases in patients with pulmonary shadow

PurposeThis study aims to assess the diagnostic accuracy of cellular analysis of bronchoalveolar lavage fluid (BALF) in distinguishing between pulmonary infectious and non-infectious diseases in patients with pulmonary shadows. Additionally, it will develop and validate a novel scoring system based...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiyang Li, Ting Wang, Faming Liu, Juan Wang, Xiaojian Qiu, Jie Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1496088/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849721941404942336
author Jiyang Li
Ting Wang
Faming Liu
Juan Wang
Xiaojian Qiu
Jie Zhang
author_facet Jiyang Li
Ting Wang
Faming Liu
Juan Wang
Xiaojian Qiu
Jie Zhang
author_sort Jiyang Li
collection DOAJ
description PurposeThis study aims to assess the diagnostic accuracy of cellular analysis of bronchoalveolar lavage fluid (BALF) in distinguishing between pulmonary infectious and non-infectious diseases in patients with pulmonary shadows. Additionally, it will develop and validate a novel scoring system based on a nomogram for the purpose of differential diagnosis.MethodsA retrospective analysis was conducted involving data from 222 patients with pulmonary shadows, whose etiological factors were determined at our institution. The cohort was randomly allocated into a training set comprising 155 patients and a validation set of 67 patients, (ratio of 7:3), the least absolute shrinkage and selection operator (LASSO) regression model was applied to optimize feature selection for the model. Multivariable logistic regression analysis was applied to construct a predictive model. The receiver operating characteristic curve (ROC) and calibration curve were utilized to assess the prediction accuracy of the model. Decision curve analysis (DCA) and clinical impact curve (CIC) were employed to evaluate the clinical applicability of the model. Moreover, model comparison was set to evaluate the discrimination and clinical usefulness between the nomogram and the risk factors.ResultsAmong the relevant predictors, the percentage of neutrophils in BALF (BALF NP) exhibited the most substantial differentiation, as evidenced by the largest area under the ROC curve (AUC = 0.783, 95% CI: 0.713–0.854). A BALF NP threshold of ≥16% yielded a sensitivity of 72%, specificity of 70%, a positive likelihood ratio of 2.07, and a negative likelihood ratio of 0.38. LASSO and multivariate regression analyses indicated that BALF NP (p < 0.001, OR = 1.04, 95% CI: 1.02–1.06) and procalcitonin (p < 0.021, OR = 52.60, 95% CI: 1.83–1510.06) serve as independent predictors of pulmonary infection. The AUCs for the training and validation sets were determined to be 0.853 (95% CI: 0.806–0.918) and 0.801 (95% CI: 0.697–0.904), respectively, with calibration curves demonstrating strong concordance. The DCA and CIC analyses indicated that the nomogram model possesses commendable clinical applicability. In models comparison, ROC analyses revealed that the nomogram exhibited superior discriminatory accuracy compared to alternative models, with DCA further identifying the nomogram as offering the highest net benefits across a broad spectrum of threshold probabilities.ConclusionBALF NP ≥16% serves as an effective discriminator between pulmonary infectious and non-infectious diseases in patients with pulmonary shadows. We have developed a nomogram model incorporating BALF NP and procalcitonin (PCT), which has proven to be a valuable tool for predicting the risk of pulmonary infections. This model holds significant potential to assist clinicians in making informed treatment decisions.
format Article
id doaj-art-2a2bc744264c45cb954ddbc7c89b1b3b
institution DOAJ
issn 2296-858X
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-2a2bc744264c45cb954ddbc7c89b1b3b2025-08-20T03:11:30ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-11-011110.3389/fmed.2024.14960881496088Diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non-infectious diseases in patients with pulmonary shadowJiyang Li0Ting Wang1Faming Liu2Juan Wang3Xiaojian Qiu4Jie Zhang5Department of Respiratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Respiratory, Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, ChinaDepartment of Respiratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Respiratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Respiratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Respiratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaPurposeThis study aims to assess the diagnostic accuracy of cellular analysis of bronchoalveolar lavage fluid (BALF) in distinguishing between pulmonary infectious and non-infectious diseases in patients with pulmonary shadows. Additionally, it will develop and validate a novel scoring system based on a nomogram for the purpose of differential diagnosis.MethodsA retrospective analysis was conducted involving data from 222 patients with pulmonary shadows, whose etiological factors were determined at our institution. The cohort was randomly allocated into a training set comprising 155 patients and a validation set of 67 patients, (ratio of 7:3), the least absolute shrinkage and selection operator (LASSO) regression model was applied to optimize feature selection for the model. Multivariable logistic regression analysis was applied to construct a predictive model. The receiver operating characteristic curve (ROC) and calibration curve were utilized to assess the prediction accuracy of the model. Decision curve analysis (DCA) and clinical impact curve (CIC) were employed to evaluate the clinical applicability of the model. Moreover, model comparison was set to evaluate the discrimination and clinical usefulness between the nomogram and the risk factors.ResultsAmong the relevant predictors, the percentage of neutrophils in BALF (BALF NP) exhibited the most substantial differentiation, as evidenced by the largest area under the ROC curve (AUC = 0.783, 95% CI: 0.713–0.854). A BALF NP threshold of ≥16% yielded a sensitivity of 72%, specificity of 70%, a positive likelihood ratio of 2.07, and a negative likelihood ratio of 0.38. LASSO and multivariate regression analyses indicated that BALF NP (p < 0.001, OR = 1.04, 95% CI: 1.02–1.06) and procalcitonin (p < 0.021, OR = 52.60, 95% CI: 1.83–1510.06) serve as independent predictors of pulmonary infection. The AUCs for the training and validation sets were determined to be 0.853 (95% CI: 0.806–0.918) and 0.801 (95% CI: 0.697–0.904), respectively, with calibration curves demonstrating strong concordance. The DCA and CIC analyses indicated that the nomogram model possesses commendable clinical applicability. In models comparison, ROC analyses revealed that the nomogram exhibited superior discriminatory accuracy compared to alternative models, with DCA further identifying the nomogram as offering the highest net benefits across a broad spectrum of threshold probabilities.ConclusionBALF NP ≥16% serves as an effective discriminator between pulmonary infectious and non-infectious diseases in patients with pulmonary shadows. We have developed a nomogram model incorporating BALF NP and procalcitonin (PCT), which has proven to be a valuable tool for predicting the risk of pulmonary infections. This model holds significant potential to assist clinicians in making informed treatment decisions.https://www.frontiersin.org/articles/10.3389/fmed.2024.1496088/fullbronchoalveolar lavage fluidcellular analysisnomogrampulmonary infectious diseasespulmonary non-infectious disease
spellingShingle Jiyang Li
Ting Wang
Faming Liu
Juan Wang
Xiaojian Qiu
Jie Zhang
Diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non-infectious diseases in patients with pulmonary shadow
Frontiers in Medicine
bronchoalveolar lavage fluid
cellular analysis
nomogram
pulmonary infectious diseases
pulmonary non-infectious disease
title Diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non-infectious diseases in patients with pulmonary shadow
title_full Diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non-infectious diseases in patients with pulmonary shadow
title_fullStr Diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non-infectious diseases in patients with pulmonary shadow
title_full_unstemmed Diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non-infectious diseases in patients with pulmonary shadow
title_short Diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non-infectious diseases in patients with pulmonary shadow
title_sort diagnostic test accuracy of cellular analysis of bronchoalveolar lavage fluid in distinguishing pulmonary infectious and non infectious diseases in patients with pulmonary shadow
topic bronchoalveolar lavage fluid
cellular analysis
nomogram
pulmonary infectious diseases
pulmonary non-infectious disease
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1496088/full
work_keys_str_mv AT jiyangli diagnostictestaccuracyofcellularanalysisofbronchoalveolarlavagefluidindistinguishingpulmonaryinfectiousandnoninfectiousdiseasesinpatientswithpulmonaryshadow
AT tingwang diagnostictestaccuracyofcellularanalysisofbronchoalveolarlavagefluidindistinguishingpulmonaryinfectiousandnoninfectiousdiseasesinpatientswithpulmonaryshadow
AT famingliu diagnostictestaccuracyofcellularanalysisofbronchoalveolarlavagefluidindistinguishingpulmonaryinfectiousandnoninfectiousdiseasesinpatientswithpulmonaryshadow
AT juanwang diagnostictestaccuracyofcellularanalysisofbronchoalveolarlavagefluidindistinguishingpulmonaryinfectiousandnoninfectiousdiseasesinpatientswithpulmonaryshadow
AT xiaojianqiu diagnostictestaccuracyofcellularanalysisofbronchoalveolarlavagefluidindistinguishingpulmonaryinfectiousandnoninfectiousdiseasesinpatientswithpulmonaryshadow
AT jiezhang diagnostictestaccuracyofcellularanalysisofbronchoalveolarlavagefluidindistinguishingpulmonaryinfectiousandnoninfectiousdiseasesinpatientswithpulmonaryshadow